ASX Share rice
Tue 18 May 2021 - 11:30:am (Sydney)

TDL Share Price

TBG DIAGNOSTICS LIMITEDTDLPharmaceuticals, Biotechnology & Life Sciences

TDL Company Information

Name:

TBG Diagnostics Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

138 Juliette Street Greenslopes QLD Australia 4120

Phone:

61 7 3088 7926

Exec. Chairman:

Mr. Indrajit Solomon Arulampalam

CFO & GM of Fin.:

Ms. Generosa Hipona

Company Sec.:

Mr. Justyn Peter Stedwell B.Com., B.Com

Chief Operating Officer:

Mr. Willy M. Hsu

Chief Scientific Officer:

Dr. Michael Chen

Head of Biology:

Dr. Edward Hammond

Head of Chemistry:

Dr. Paul Handley

Head of Process Chemistry:

Dr. Tomislav Karoli

Pres of TBG (Xiamen) Inc:

Mr. Ifan Chiu

Company Overview:

TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in Taiwan and China. It provides ExProbe HLA and HPA kits for human leukocyte antigen (HLA) and human platelet antigens (HPA) allele genotyping, which uses real time polymerase chain reaction (PCR) techniques with sequence specific primers and probes; Morgan SSP HLA kits for determining HLA alleles using PCR techniques with sequence specific primers; HLAssure SBT HLA Kits for transplantation donor selection; and AccuType SBT analysis software to analyze sequences from all ab1 based files. The company also offers Morgan SSPal HLA Typing Analysis Software, a gel result interpretation software; HLA typing services that offer low to high resolution using PCR fragment analysis (SSP) and DNA sequencing (SBT); QPCR Q6000, a six-channel real time PCR instrument; QzNGS NGS that provides high resolution HLA genotyping; and COVID-19 testing kits. It serves clinical labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 is based in Greenslopes, Australia.

TDL Share Price Information

Shares Issued:

217.59M

Market Capitalisation:

$58.75M

Revenue (TTM):

$4.61M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$0.003

Profit Margin:

-0.7705

Operating Margin (TTM):

$-0.74

Return On Assets (TTM):

$-0.14

Return On Equity (TTM):

$-0.38

Quarterly Revenue Growth (YOY):

0.229

Gross Profit(TTM):

$2.66M

Diluted Earnings Per Share (TTM):

$-0.016

TDL CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-75,000

Change To Liabilities:

$4.76M

Total Cashflow From Investing Activities:

$-287,391

Net Borrowings:

$2.09M

Net Income:

$-3,548,975

Total Cash From Operating Activities:

$-3,391,511

Depreciation:

$773.37K

Other Cashflow From Investing Activities:

$-75,000

Change To Inventory:

$-4,187,227

Change To Account Receivables:

$-297,732

Capital Expenditures:

$130.20K

TDL Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-3,548,975

Net Income:

$-3,548,975

Gross Profit:

$2.66M

Operating Income:

$-3,411,054

Interest Expense:

$11.83K

Total Revenue:

$4.61M

Cost Of Revenue:

$1.95M

TDL Balance Sheet

Balance Sheet Date:

2020-12-31

Total Liabilities:

$9.09M

Total Stockholder Equity:

$5.80M

Other Current Liabilities:

$3.92M

Total Assets:

$14.88M

Common Stock:

$36.21M

Other Current Assets:

$184.84K

Retained Earnings:

$-30,985,935

Other Assets:

$99.24K

Cash:

$3.78M

Total Current Liabilities:

$7.74M

Short-Term Debt:

$2.77M

Property - Plant & Equipment:

$1.76M

Net Tangible Assets:

$5.80M

Long-Term Investments:

$2.99M

Total Current Assets:

$10.03M

Long-Term Debt:

$449.26K

Net Receivables:

$773.60K

Short-Term Investments:

$5.04M

Inventory:

$5.04M

Accounts Payable:

$790.05K

Non Currrent Assets (Other):

$284.08K

Short-Term Investments:

$5.04

Non Current Liabilities Total:

$1.34M

TDL Share Price History

TDL News